Medicare Enrolled
Dr. Srirama Kalapatapu, M.D.
Cardiovascular Disease · Scarsdale, NY
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Speaking/Promotional
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Kalapatapu from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Kalapatapu?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Kalapatapu
Dr. Srirama Kalapatapu is a cardiovascular disease specialist in Scarsdale, NY, with 20 years of NPI registration. Based on federal Medicare data, Dr. Kalapatapu performed 5,004 Medicare services across 2,987 unique beneficiaries.
Between the years covered by Open Payments, Dr. Kalapatapu received a total of $178,250 from 47 pharmaceutical and/or device companies across 1242 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in cardiovascular disease. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Kalapatapu is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 12% volume in NY
$178,250 industry payments
Medicare Practice Summary
Medicare Utilization ↗5,004
Medicare services
Top 12% in NY for cardiovascular disease
2,987
Unique beneficiaries
$66
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~250 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
1,357 | $105 | $530 |
| Electrocardiogram (EKG), 12-lead A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report. |
1,194 | $13 | $90 |
| EKG interpretation and report A standard electrocardiogram test that records the heart's electrical activity using at least 12 leads. The service includes a professional interpretation of the results and a written report. |
1,158 | $7 | $60 |
| Echocardiogram, transthoracic An ultrasound of the heart that uses color to show blood flow, rate, direction, and valve function. |
326 | $178 | $1,770 |
| Regadenoson injection (Lexiscan) for heart stress test An injection of regadenoson, a medication used to stress the heart during diagnostic testing. |
184 | $42 | $101 |
| Technetium Tc-99m sestamibi diagnostic injection A diagnostic injection of technetium Tc-99m sestamibi used for imaging studies. |
145 | $97 | $564 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
102 | $74 | $290 |
| Exercise or drug-induced heart stress test with ECG A heart stress test performed using exercise or medication while monitoring the electrocardiogram under physician supervision and review. |
85 | $58 | $380 |
| Nuclear stress test of heart muscle A nuclear medicine imaging test that evaluates blood flow to the heart muscle at rest and during stress using a special camera. |
73 | $417 | $3,960 |
| New patient office visit, complex (60-74 min) | 70 | $190 | $832 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
64 | $161 | $800 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
51 | $159 | $740 |
| Flu vaccine administration This procedure involves the administration of the influenza virus vaccine. It covers the process of delivering the vaccine to the patient. |
45 | $35 | $120 |
| Flu vaccine, high-dose High-dose seasonal influenza vaccine for adults aged 65 and older. Contains four times the antigen of standard-dose flu vaccines (60 mcg per strain), split-virus formulation, preservative-free, single-dose syringe. |
44 | $72 | $130 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
38 | $8 | $26 |
| Hospital discharge management, 30+ min This service covers the care provided by a physician or qualified healthcare professional on the day a patient is discharged from the hospital. It requires more than 30 minutes of total time spent on the day of discharge. |
25 | $108 | $430 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
15 | $103 | $433 |
| Exercise or drug-induced heart stress test with ECG A heart stress test performed using exercise or medication while an electrocardiogram is monitored under physician supervision. |
14 | $17 | $120 |
| Exercise or drug-induced heart stress test with ECG A heart stress test performed using exercise or medication while monitoring the electrocardiogram, with physician review of the results. |
14 | $12 | $90 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
6.5% high complexity
10.3% medium
83.2% routine
Industry Payment Transparency
Open Payments through 2024 ↗$178,250
Total received (2018-2024)
Avg $25,464/year across 7 years
Top 3% in NY for cardiovascular disease
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
47
Companies
1,242
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$136,100 (76.4%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$36,563 (20.5%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$5,588 (3.1%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$25,546
2023
$20,190
2022
$28,388
2021
$21,606
2020
$22,692
2019
$40,612
2018
$19,215
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Boehringer Ingelheim Pharmaceuticals, Inc.
$18,667
Lilly USA, LLC
$3,782
Abbott Laboratories
$507
Novo Nordisk Inc
$336
Novartis Pharmaceuticals Corporation
$320
Boston Scientific Corporation
$316
Amgen Inc.
$227
BIOTRONIK INC.
$211
Janssen Pharmaceuticals, Inc
$173
Merck Sharp & Dohme LLC
$155
Medtronic, Inc.
$149
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$123
AstraZeneca Pharmaceuticals LP
$81
SCPHARMACEUTICALS INC.
$81
E.R. Squibb & Sons, L.L.C.
$75
PFIZER INC.
$66
Esperion Therapeutics, Inc.
$64
Lexicon Pharmaceuticals, Inc.
$45
Celgene Corporation
$42
Bayer Healthcare Pharmaceuticals Inc.
$41
IRONWOOD PHARMACEUTICALS, INC
$37
GlaxoSmithKline, LLC.
$32
iRhythm Technologies, Inc.
$17
Top 3 companies account for 89.9% of 2024 payments
All-time payments by company (2018-2024) ›
Boehringer Ingelheim Pharmaceuticals, Inc.
$123,692
Lilly USA, LLC
$17,995
BIOTRONIK INC.
$5,717
Boston Scientific Corporation
$3,945
AstraZeneca Pharmaceuticals LP
$2,767
Novartis Pharmaceuticals Corporation
$2,613
Janssen Pharmaceuticals, Inc
$2,393
Medtronic Vascular, Inc.
$2,290
E.R. Squibb & Sons, L.L.C.
$2,220
Amgen Inc.
$2,001
Abbott Laboratories
$1,873
PFIZER INC.
$1,676
Medtronic, Inc.
$1,343
Novo Nordisk Inc
$1,329
BOSTON SCIENTIFIC CORPORATION
$1,013
Amarin Pharma Inc.
$769
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$564
Merck Sharp & Dohme LLC
$521
Kowa Pharmaceuticals America, Inc.
$440
Janssen Scientific Affairs, LLC
$237
Celgene Corporation
$223
Lundbeck LLC
$219
Esperion Therapeutics, Inc.
$216
Regeneron Healthcare Solutions, Inc.
$198
Daiichi Sankyo Inc.
$178
ARALEZ PHARMACEUTICALS US INC.
$175
Merck Sharp & Dohme Corporation
$159
GlaxoSmithKline, LLC.
$156
SANOFI-AVENTIS U.S. LLC
$142
Gilead Sciences, Inc.
$132
Bayer HealthCare Pharmaceuticals Inc.
$127
SCPHARMACEUTICALS INC.
$119
NOVARTIS PHARMACEUTICALS CORPORATION
$113
Bardy Diagnostics, Inc.
$101
bioMerieux Inc
$91
Allergan Inc.
$80
Ironwood Pharmaceuticals, Inc
$73
iRhythm Technologies, Inc.
$62
PORTOLA PHARMACEUTICALS, INC.
$60
Lexicon Pharmaceuticals, Inc.
$45
Bayer Healthcare Pharmaceuticals Inc.
$41
IRONWOOD PHARMACEUTICALS, INC
$37
CARDIVA MEDICAL, INC.
$30
American Regent
$21
ARBOR PHARMACEUTICALS, INC.
$19
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$19
InfoBionic, Inc
$17
Top 3 companies account for 82.7% of all-time payments
Associated products mentioned in payments ›
AMVIA EDGE · ANDEXXA · AVEIR · AZURE XT DR MRI SURESCAN · Acticor · Acticor 7 VR-T DX · Adempas · Amplia MRI · Azure · BIOMONITOR · BRILINTA · BYSTOLIC · CAMZYOS · CHANTIX · COBALT DR MRI SURESCAN · CONFIRM RX · Cardiva VASCADE 6/7F VCS · Carnation Ambulatory Monitor · Claria MRI · Cobalt · Confirm Rx · Corlanor · DAKLINZA · ELIQUIS · ENTRESTO · Edarbi · Edora · FARXIGA · FORTIFY ASSURA · FUROSCIX · HeartMate · HeartMate 3 Left Ventricular Assist Device · HeartMate 3 Left Ventricular Dev · INJECTAFER · JARDIANCE · JOT DX · Kerendia · LEQVIO · LINQ II · LOKELMA · LUX-Dx Insertable Cardiac Monitor · LifeVest · Linzess · Livalo · MICRA · MOUNJARO · MULTAQ · Micra · Mitra Clip system · MoMe Kardia · Movantik · NEXLETOL · NORTHERA · Ozempic · PRADAXA · PRALUENT · PRALUENT ALIROCUMAB INJECTION · PULMICORT TURBUHALER · Quadra Allure MP RF CRT Pacemkr · REVEAL LINQ · RYBELSUS · Repatha · Reveal LINQ · Rivacor 7 DR-T · Rybelsus · Solia · Supera peripheral stent system · TRELEGY ELLIPTA · VERQUVO · VYNDAMAX · VYNDAQEL · Vascepa · WATCHMAN · WATCHMAN Access System · WATCHMAN FLX · Wegovy · XARELTO · XIFAXAN · ZIO XT Patch · ZONTIVITY · Zio monitor
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (76%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in cardiovascular disease and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 3% for cardiovascular disease in NY.
Geographic Context
Cardiologists within 10 mi
1,659
Per 100K population
166.4
County median income
$118,411
Nearest hospital
WHITE PLAINS HOSPITAL CENTER
3.3 mi
3.3 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Kalapatapu is a clinical cardiology specialist, with above-average Medicare volume (top 12% in NY), with speaking/promotional industry engagement in the top 3% of NY peers, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Kalapatapu experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Kalapatapu performed 1,357 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Kalapatapu receive payments from pharmaceutical companies?
Yes. Dr. Kalapatapu received a total of $178,250 from 47 companies across 1,242 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Kalapatapu's costs compare to other cardiologists in Scarsdale?
Dr. Kalapatapu's average Medicare payment per service is $66. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Kalapatapu) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Cardiologists in Scarsdale
Browse cardiologists in Scarsdale ranked by procedure volume and transparency data.
Highest volume
Top Cardiologists in NY
Cardiologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Cardiologists in NY
Which NY cardiologists receive the most from drug and device companies.
By company
Boehringer Ingelheim Pharmaceuticals, Inc. Payments to Doctors
See all physicians who received payments from Boehringer Ingelheim Pharmaceuticals, Inc.
By company
Lilly USA, LLC Payments to Doctors
See all physicians who received payments from Lilly USA, LLC.
By company
BIOTRONIK INC. Payments to Doctors
See all physicians who received payments from BIOTRONIK INC.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology